The gut microbiota is a dynamic and highly diverse microbial ecosystem that affects many
aspects of the host's physiology. An improved understanding of the gut microbiota could …

Fungal pathogens present a growing threat to both humans and global health security alike.
Increasing evidence of antifungal resistance in fungal populations that infect both humans …

In the ongoing battle against antimicrobial resistance, phenotypic drug tolerance poses a
formidable challenge. This adaptive ability of microorganisms to withstand drug pressure …

The use of antifungal drugs started in the 1950s with polyenes nystatin, natamycin and
amphotericin B-deoxycholate (AmB). Until the present day, AmB has been considered to be …

Infections by fungal pathogens are difficult to treat due to a paucity of antifungals and
emerging resistances. Next-generation antifungals therefore are needed urgently. We have …

Objectives The principal objectives of this review were to gather information on the potential
role of antihistamines as anti-infective agents and to identify the gaps in research that have …

Cryptococcosis is a systemic mycosis affecting immunosuppressed individuals, caused by
various Cryptococcus species. The current treatment utilizes a combination of antifungal …

Cryptococcus neoformans is an opportunistic fungal pathogen with significant medical
importance, especially in immunosuppressed patients. It is the causative agent of …

Pathogenic fungi are an increasing public health concern. The emergence of antifungal
resistance coupled with the scarce antifungal arsenal highlights the need for novel …

The application of nanotechnology in antifungal therapy is gaining increasing attention.
Current antifungal drugs have significant limitations, such as severe side effects, low …